G&E - Taxotere Lawsuit Blog - Free Consultations Available

Blog

First Taxotere Bellwether Trial Slated to Begin September 2019

Posted On: May 8, 2019 Posted In: Blog, Defective Drugs

The first bellwether trial in the Taxotere litigation has been scheduled for September 2019—just one of more than 12,000 liability lawsuits claiming that the chemotherapy drug’s manufacturer, Sanofi-Aventis, failed to adequately warn patients that permanent hair loss may result from taking the drug. U.S. District Judge Jane Triche Milazzo in the Eastern District of Louisiana . . Read More »

Bellwether Trials in Taxotere Lawsuit to Begin May 2019

Posted On: July 18, 2018 Posted In: Blog, Defective Drugs

On June 13th, the federal court overseeing thousands of Taxotere lawsuits ordered that bellwether trials will begin in May 2019. Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. Recently, over 8,700 lawsuits have been filed alleging that alopecia (hair loss) caused by this drug is far more likely to be permanent compared to equally-effective alternative medications. . . Read More »

Categories

Archives

Do You Suffer from Taxotere Side-Effects,
Such as Permanent Hair Loss?

Blog

First Taxotere Bellwether Trial Slated to Begin September 2019

Bellwether Trials in Taxotere Lawsuit to Begin May 2019

Categories

Archives

Do You Suffer from Taxotere Side-Effects, Such as Permanent Hair Loss?

Blog

Do You Suffer from Taxotere Side-Effects,
Such as Permanent Hair Loss?